Sanai Health Industry Group Co (HKSE:01889) GF Value : HK$0.06 (As of Jun. 06, 2024)

View and export this data going back to 2007. Start your Free Trial

What is Sanai Health Industry Group Co GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-06-06), Sanai Health Industry Group Co's share price is HK$0.025. Sanai Health Industry Group Co's GF Value is HK$0.06. Therefore, Sanai Health Industry Group Co's Price-to-GF-Value for today is 0.42.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Sanai Health Industry Group Co is Possible Value Trap, Think Twice.

Sanai Health Industry Group Co (HKSE:01889) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Sanai Health Industry Group Co's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	0.025	/	0.06
	=	0.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sanai Health Industry Group Co GF Value Related Terms

Thank you for viewing the detailed overview of Sanai Health Industry Group Co's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Sanai Health Industry Group Co (HKSE:01889) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanai Health Industry Group Co Ltd (HKSE:01889) » Definitions » GF Value

Traded in Other Exchanges

WUP:Germany

Address

57 Hung To Road, Unit 5, 7th Floor, Nanyang Plaza, Kwun Tong, Kowloon, Hong Kong, HKG

Website

http://www.1889hk.com

Sanai Health Industry Group Co Ltd is a pharmaceutical company. The company has three reportable segments namely Pharmaceutical products includes development, manufacturing, marketing and sales of pharmaceutical products and related software and provision of consultancy services. Finance leasing includes the provision of financial leasing services; Genetic testing and molecular diagnostic services segment. It generates maximum revenue from Pharmaceutical products segments. Geographically, it derives a majority revenue from PRC.

Executives

Zhi Shaohuan	2101 Beneficial owner
Jiang Hengguang
Yang Youju	2201 Interest of corporation controlled by you
Yuan Chaoyang	2101 Beneficial owner
Cyber Success Global Investments Limited	2101 Beneficial owner

Sanai Health Industry Group Co (HKSE:01889) Headlines

No Headlines